The Global Oxygen Therapy Equipment Market is expected to witness a growth rate of 6-7% in the next five years. Increasing ...

For users requiring stationary oxygen therapy, VARON's Serene 5 and VH-2 PRO models offer dependable medical-grade oxygen ...

Get ready to experience the best of Taiwan’s award-winning innovations at the Taiwan Excellence Pavilion, taking place from ...

Offering milder temperatures, these devices are more suitable for people with ailments like high blood pressure, heart ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, w | Drug Discovery And Development ...

At current levels, GRFS scores over ADMA with cheaper valuation, a broad portfolio, and strong EPS growth estimates despite the latter's robust Asceniv-driven momentum.

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB. Explore delivery mechanisms, key technologies, and future breakthroughs.

Vitamin C is essential for a robust immune response to tuberculosis, and its deficiency can elevate the risk of TB and ...

Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, Effect of Single-Prong Cannula Design with High Velocity ...

Sanofi faces setbacks after itepekimab’s Phase 3 COPD failure, removing a key growth prospect and highlighting reliance on ...

Remote study conducted at Rutgers and elsewhere finds albuterol-budesonide mix cuts risk for mild cases and may let patients skip daily maintenance drugs.